Edward White sees positive road ahead after SPPI’s compelling cancer asset hits ORR of 73% in Exon 20.
Spectrum Pharmaceuticals, Inc.(NASDAQ:SPPI) is a mover and shaker out on the Street today, with investors sparking the stock on an almost 50% upturn.